rifaximin
Showing 1 - 25 of 101
Crohn Disease, Diabetic Gastroparesis Trial in Jacksonville (Rifaximin, Placebo)
Recruiting
- Crohn Disease
- Diabetic Gastroparesis
- Rifaximin
- Placebo
-
Jacksonville, FloridaMayo Clinic in Florida
Dec 12, 2022
Healthy Volunteers, Stress, Fear Trial in Leuven (Rifaximin, Placebo)
Not yet recruiting
- Healthy Volunteers
- +2 more
- Rifaximin
- Placebo
-
Leuven, BelgiumUZ/KU Leuven
Oct 17, 2022
Severe Hepatic Impairment Trial in San Antonio (Rifaximin)
Recruiting
- Severe Hepatic Impairment
- Rifaximin
-
San Antonio, TexasValeant Site 01
Sep 7, 2022
Liver Cirrhosis, Renal Failure Trial in New York (Rifaximin, Lactulose)
Withdrawn
- Liver Cirrhosis
- Renal Failure
- Rifaximin
- Lactulose
-
New York, New YorkWeill Cornell Medical Center
Jan 24, 2022
Small Intestinal Bacterial Overgrowth, Liver Cirrhosis Trial in Mexico (Rifaximin, Placebo)
Terminated
- Small Intestinal Bacterial Overgrowth
- Liver Cirrhosis
- Rifaximin
- Placebo
-
Mexico, Ciudad De Mexico, MexicoCentro Médico Nacional Siglo XXI
Mar 7, 2022
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8 Trial
Recruiting
- Anatomic Stage I Breast Cancer AJCC v8
- +20 more
- Best Practice
- +2 more
-
Jacksonville, FloridaMayo Clinic in Florida
Jan 5, 2023
Crohn's Disease Trial in Seattle (Placebo Comparator, Rifaximin)
Completed
- Crohn's Disease
- Placebo Comparator
- Rifaximin
-
Seattle, WashingtonUniversity of Washington Medical Center
Dec 1, 2021
Microbial Colonization Trial in Atlanta (Rifaximin)
Completed
- Microbial Colonization
- Rifaximin
-
Atlanta, GeorgiaChildren's Healthcare of Atlanta
Oct 8, 2021
Chronic Kidney Disease Trial in Kansas City (Rifaximin, Placebo)
Completed
- Chronic Kidney Disease
- Rifaximin
- Placebo
-
Kansas City, KansasUniversity of Kansas Medical Center
Oct 8, 2021
Visceral Hypersensitivity, Irritable Bowel Syndrome Trial in Los Angeles (Rifaximin)
Terminated
- Visceral Hypersensitivity
- Irritable Bowel Syndrome
- Rifaximin
-
Los Angeles, CaliforniaCedars-Sinai Medical Center
Nov 19, 2021
Irritable Bowel Syndrome, Small Intestinal Bacterial Overgrowth Trial in Girona (Probiotic, Rifaximin)
Terminated
- Irritable Bowel Syndrome
- Small Intestinal Bacterial Overgrowth
- Probiotic
- Rifaximin
-
Girona, SpainDr. Bofill Clinic
Nov 2, 2022
Irritable Bowel Syndrome, Irritable Bowel Syndrome With Diarrhea Trial in Ann Arbor (Rifaximin, Glucose and lactulose hydrogen
Recruiting
- Irritable Bowel Syndrome
- Irritable Bowel Syndrome With Diarrhea
- Rifaximin
- Glucose and lactulose hydrogen breath testing
-
Ann Arbor, MichiganUniversity of Michigan
Dec 1, 2021
IgA Monoclonal Gammopathy, IgG Monoclonal Gammopathy, IgM Monoclonal Gammopathy Trial in Atlanta (Rifaximin)
Recruiting
- IgA Monoclonal Gammopathy
- +8 more
- Rifaximin
-
Atlanta, GeorgiaEmory University Hospital/Winship Cancer Institute
Oct 18, 2021
Clostridium Difficile Infection Trial in Nottingham (Rifaximin, Placebo)
Completed
- Clostridium Difficile Infection
- Rifaximin
- Placebo
-
Nottingham, Nottinghamshire, United KingdomNottingham Clinical Trials Unit (NCTU), Queen's Medical Centre
Oct 5, 2021
Cirrhosis, Liver, Minimal Hepatic Encephalopathy, Small Intestinal Bacterial Overgrowth Trial in Cleveland (Rifaximin)
Recruiting
- Cirrhosis, Liver
- +3 more
- Rifaximin
-
Cleveland, OhioMetrohealth Medical Center
Nov 23, 2021
Irritable Bowel Syndrome Trial in Shanghai (Rifaximin, Fecal microbiota transplantation)
Recruiting
- Irritable Bowel Syndrome
- Rifaximin
- Fecal microbiota transplantation
-
Shanghai, ChinaZhongshan Hospital, Fudan University
Dec 29, 2021
Cirrhosis, Ascites, Peritonitis Trial in France (Rifaximin, Placebo)
Active, not recruiting
- Cirrhosis
- +2 more
- Rifaximin
- Placebo
-
Amiens, France
- +17 more
Jul 12, 2022
Irritable Bowel Syndrome With Diarrhea Trial in Los Angeles (Rifaximin, N-acetylcysteine, Placebo)
Active, not recruiting
- Irritable Bowel Syndrome With Diarrhea
- Rifaximin
- +2 more
-
Los Angeles, CaliforniaCedars-Sinai Medical Center
Nov 3, 2021
Covert Hepatic Encephalopathy Trial in Shanghai (Rifaximin)
Completed
- Covert Hepatic Encephalopathy
- Rifaximin
-
Shanghai, Shanghai, ChinaShanghai changzheng Hospital
Jun 28, 2021
Parkinson Disease Trial in San Francisco (Rifaximin, Placebo)
Recruiting
- Parkinson Disease
- Rifaximin
- Placebo
-
San Francisco, CaliforniaUniversity of California San Francisco
Oct 25, 2022
Irritable Bowel Syndrome, Small Intestinal Bacterial Overgrowth Trial in Kuala Lumpur (Rifaximin, Low FODMAP diet)
Recruiting
- Irritable Bowel Syndrome
- Small Intestinal Bacterial Overgrowth
- Rifaximin
- Low FODMAP diet
-
Kuala Lumpur, MalaysiaUniversity Malaya Medical Centre
May 4, 2021
Hepatic Encephalopathy Trial (Rifaximin)
Completed
- Hepatic Encephalopathy
- Rifaximin
- (no location specified)
Feb 1, 2021
Liver Cirrhosis, Chronic Hepatitis C Trial in Philadelphia (Rifaximin, Placebo)
Terminated
- Liver Cirrhosis
- Chronic Hepatitis C
- Rifaximin
- Placebo
-
Philadelphia, PennsylvaniaPhiladelphia VA Medical Center
Mar 8, 2021
Spontaneous Bacterial Peritonitis Trial in Foggia (Rifaximin, Norfloxacin)
Active, not recruiting
- Spontaneous Bacterial Peritonitis
- Rifaximin
- Norfloxacin
-
Foggia, ItalyOspedali Riuniti Foggia
Feb 15, 2021
Small Intestinal Bacterial Overgrowth Trial in Woolloongabba, Lucknow (device, diagnostic test, procedure, drug)
Recruiting
- Small Intestinal Bacterial Overgrowth
- Atmo Gas Capsule
- +5 more
-
Woolloongabba, Queensland, Australia
- +1 more
Jul 19, 2022